17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial
- PMID: 22270303
- DOI: 10.1097/AOG.0b013e318244b0ef
17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial
Comment on
-
17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.Obstet Gynecol. 2011 Sep;118(3):513-520. doi: 10.1097/AOG.0b013e31822ad6aa. Obstet Gynecol. 2011. PMID: 21860279 Clinical Trial.
Similar articles
-
17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.Obstet Gynecol. 2011 Sep;118(3):513-520. doi: 10.1097/AOG.0b013e31822ad6aa. Obstet Gynecol. 2011. PMID: 21860279 Clinical Trial.
-
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.N Engl J Med. 2007 Aug 2;357(5):454-61. doi: 10.1056/NEJMoa070641. N Engl J Med. 2007. PMID: 17671253 Clinical Trial.
-
Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.J Matern Fetal Neonatal Med. 2007 Mar;20(3):249-52. doi: 10.1080/14767050601152845. J Matern Fetal Neonatal Med. 2007. PMID: 17437227
-
Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.Am J Obstet Gynecol. 2016 Jan;214(1):45-56. doi: 10.1016/j.ajog.2015.10.934. Epub 2015 Nov 10. Am J Obstet Gynecol. 2016. PMID: 26558340 Review.
-
Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.Am J Obstet Gynecol. 2013 Jun;208(6):421-6. doi: 10.1016/j.ajog.2013.04.027. Epub 2013 Apr 30. Am J Obstet Gynecol. 2013. PMID: 23643669 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources